Budesonide non-comp unit
Products billed under this code include Budesonide, Pulmicort.
Payment limit per 0.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Budesonide, Pulmicort.
Payment limit per 0.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Budesonide | Teva Pharmaceuticals USA, Inc. | 00093-6815-55 | 30 | $27.69 |
| Budesonide | Teva Pharmaceuticals USA, Inc. | 00093-6815-73 | 30 | $27.69 |
| Budesonide | Teva Pharmaceuticals USA, Inc. | 00093-6816-55 | 30 | $27.69 |
| Budesonide | Teva Pharmaceuticals USA, Inc. | 00093-6816-73 | 30 | $27.69 |
| Budesonide | Teva Pharmaceuticals USA, Inc. | 00093-6817-73 | 60 | $55.38 |
| Budesonide | Impax Laboratories, LLC | 00115-1687-74 | 30 | $27.69 |
| Budesonide | Impax Laboratories, LLC | 00115-1689-74 | 30 | $27.69 |
| Budesonide | Nephron SC, Inc. | 00487-9601-01 | 30 | $27.69 |
| Budesonide | Nephron SC, Inc. | 00487-9601-30 | 30 | $27.69 |
| Budesonide | Nephron SC, Inc. | 00487-9701-01 | 30 | $27.69 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Budesonide | Nephron SC, Inc. | 00487-9701-30 | 30 | $27.69 |
| Budesonide | Northstar RxLLC | 16714-0020-30 | 60 | $55.38 |
| Budesonide | Sun Pharmaceutical Global FZE. | 47335-0631-49 | 30 | $27.69 |
| Budesonide | Sun Pharmaceutical Global FZE. | 47335-0632-49 | 30 | $27.69 |
| Budesonide | Sun Pharmaceutical Global FZE. | 47335-0633-49 | 60 | $55.38 |
| Budesonide | A-S Medication Solutions | 50090-1467-00 | 30 | $27.69 |
| Budesonide | A-S Medication Solutions | 50090-6586-00 | 30 | $27.69 |
| Budesonide | A-S Medication Solutions | 50090-6590-00 | 30 | $27.69 |
| Budesonide | A-S Medication Solutions | 50090-7126-00 | 30 | $27.69 |
| Budesonide | A-S Medication Solutions | 50090-7173-00 | 30 | $27.69 |
| Budesonide | American Health Packaging | 60687-0524-83 | 30 | $27.69 |
| Budesonide | Chartwell | 62135-0822-84 | 30 | $27.69 |
| Budesonide | Chartwell | 62135-0823-84 | 30 | $27.69 |
| Budesonide | Rising Pharma Holdings, Inc. | 64980-0638-03 | 30 | $27.69 |
| Budesonide | Rising Pharma Holdings, Inc. | 64980-0639-03 | 30 | $27.69 |
| Budesonide | Lupin Pharmaceuticals, Inc. | 68180-0984-30 | 30 | $27.69 |
| Budesonide | Cipla USA, Inc. | 69097-0318-53 | 30 | $27.69 |
| Budesonide | Cipla USA, Inc. | 69097-0318-87 | 30 | $27.69 |
| Budesonide | Cipla USA, Inc. | 69097-0319-53 | 30 | $27.69 |
| Budesonide | Cipla USA, Inc. | 69097-0319-87 | 30 | $27.69 |
| Budesonide | Cipla USA, Inc. | 69097-0321-53 | 60 | $55.38 |
| Budesonide | Cipla USA, Inc. | 69097-0321-87 | 60 | $55.38 |
| Budesonide | Ritedose Pharmaceuticals, LLC | 76204-0018-01 | 30 | $27.69 |
| Budesonide | Exelan Pharmaceuticals, Inc. | 76282-0640-38 | 30 | $27.69 |
| Budesonide | Exelan Pharmaceuticals, Inc. | 76282-0641-38 | 30 | $27.69 |
| Pulmicort | AstraZeneca Pharmaceuticals LP | 00186-1988-04 | 30 | $27.69 |
| Pulmicort | AstraZeneca Pharmaceuticals LP | 00186-1989-04 | 30 | $27.69 |
| Pulmicort | AstraZeneca Pharmaceuticals LP | 00186-1990-04 | 60 | $55.38 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.923 | −$0.169 | 0.5 MG | Budesonide non-comp unit | v1, posted September 17, 2026 |
| 3Q26 | $1.092 | −$0.003 | 0.5 MG | Budesonide non-comp unit | v1, posted September 15, 2026 |
| 2Q26 | $1.095 | +$0.046 | 0.5 MG | Budesonide non-comp unit | v1, posted September 15, 2026 |
| 1Q26 | $1.049 | −$0.302 | 0.5 MG | Budesonide non-comp unit | v1, posted September 15, 2026 |
| 4Q25 | $1.351 | +$0.076 | 0.5 MG | Budesonide non-comp unit | v1, posted September 8, 2026 |
| 3Q25 | $1.275 | +$0.082 | 0.5 MG | Budesonide non-comp unit | v1, posted March 10, 2026 |
| 2Q25 | $1.193 | −$0.219 | 0.5 MG | Budesonide non-comp unit | v1, posted March 10, 2026 |
| 1Q25 | $1.412 | +$0.183 | 0.5 MG | Budesonide non-comp unit | v1, posted December 19, 2025 |
| 4Q24 | $1.229 | +$0.041 | 0.5 MG | Budesonide non-comp unit | v1, posted June 11, 2025 |
| 3Q24 | $1.188 | −$0.015 | 0.5 MG | Budesonide non-comp unit | v1, posted June 11, 2025 |
| 2Q24 | $1.203 | +$0.197 | 0.5 MG | Budesonide non-comp unit | v1, posted March 11, 2025 |
| 1Q24 | $1.006 | −$0.142 | 0.5 MG | Budesonide non-comp unit | v1, posted December 19, 2024 |
| 4Q23 | $1.148 | +$0.27 | 0.5 MG | Budesonide non-comp unit | v1, posted October 10, 2024 |
| 3Q23 | $0.878 | −$0.021 | 0.5 MG | Budesonide non-comp unit | v1, posted June 5, 2024 |
| 2Q23 | $0.899 | +$0.031 | 0.5 MG | Budesonide non-comp unit | v1, posted February 23, 2024 |
| 1Q23 | $0.868 | −$0.096 | 0.5 MG | Budesonide non-comp unit | v1, posted December 6, 2023 |
| 4Q22 | $0.964 | −$0.08 | 0.5 MG | Budesonide non-comp unit | v1, posted June 22, 2023 |
| 3Q22 | $1.044 | +$0.011 | 0.5 MG | Budesonide non-comp unit | v1, posted June 9, 2023 |
| 2Q22 | $1.033 | −$0.068 | 0.5 MG | Budesonide non-comp unit | v1, posted December 14, 2022 |
| 1Q22 | $1.101 | +$0.053 | 0.5 MG | Budesonide non-comp unit | v1, posted June 8, 2022 |
| 4Q21 | $1.048 | −$0.229 | 0.5 MG | Budesonide non-comp unit | v1, posted June 2, 2022 |
| 3Q21 | $1.277 | +$0.113 | 0.5 MG | Budesonide non-comp unit | v1, posted June 2, 2022 |
| 2Q21 | $1.164 | −$0.411 | 0.5 MG | Budesonide non-comp unit | v1, posted March 1, 2022 |
| 1Q21 | $1.575 | – | 0.5 MG | Budesonide non-comp unit | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.